Therapeutic Asset Ratings

3,186 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Metabolically Armed Bcma Car-T Cells. AL Amyloidosis	Anhui Provincial Hospital	Early P1	D (22)
Allo-Quadcar01-T Hematopoietic And Lymphoid Cell Neoplasm	AvenCell Therapeutics, Inc.	P1/2	D (22)
Anti-Cll1 Cart Cells Acute Myeloid Leukemia	920th Hospital of Joint Logistics Support Force of People's Liberation Army of China	P1/2	D (22)
Autologous Cd19/Cd20 Dual-Target Car-T Module Plasma Cell Myeloma	Beijing Biotech	P1/2	D (22)
bi-4scar gd2/psma t cells Neoplasm	Shenzhen Geno-Immune Medical Institute	P1/2	D (22)
cd123-car-nk cells Leukemia	Chongqing Precision Biotech Co., Ltd	P1/2	D (22)
cd7-specific car gene-engineered t cells Acute Myeloid Leukemia	Shenzhen Geno-Immune Medical Institute	P1/2	D (22)
cll1 car t-cells Acute Myeloid Leukemia	Tongji Hospital	P1/2	D (22)
Eb-Dtkn-401 Allogeneic Dual-Target Cspg4/Gd2 Car-Nk Cells Melanoma	Beijing Biotech	P1/2	D (22)
her2bbζ/cd19t+ t cells Renal Cell Carcinoma	Shanghai Public Health Clinical Center	P1/2	D (22)
Supcd7 Cart Cells Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1/2	D (22)
Targeting Cd276 Car T Cells Neuroblastoma	Shenzhen Geno-Immune Medical Institute	P1/2	D (22)
Cldn6 Car-T Extragonadal Germ Cell Tumor	BioNTech SE	P2	D (21)
Anti-Cd19 Car-Nk Cells Primary Central Nervous System Lymphoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	D (21)
Autologous Anti-Cd19 Car-Expressing T Lymphocytes Breast Cancer	Anusha Kalbasi	P1	D (21)
Autologous Muc1-Activated T-Cells Fallopian Tube Carcinoma	Mayo Clinic	P1	D (21)
Autologous Muc1-Activated T-Cells Ovarian Carcinoma	Mayo Clinic	P1	D (21)
Autologous Muc1-Activated T-Cells Fallopian Tube Carcinosarcoma	Mayo Clinic	P1	D (21)
b7-h3cart Ovarian Cancer	Stanford University	P1	D (21)
b7-h3-car t cells Glioblastoma	St. Jude Children's Research Hospital	P1	D (21)
b7-h3 target, car gene modified gdt cell Acute Myeloid Leukemia	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	P1	D (21)
b7-h3-targeting car-t cells Glioblastoma	Beijing Tiantan Hospital	P1	D (21)
c7r.cd30.car-ebvst cells Peripheral T-Cell Lymphoma, Not Otherwise Specified	Baylor College of Medicine	P1	D (21)
cd19car-cd28-cd3zeta-egfrt-expressing tn/mem-enriched t-lymphocytes Primary Central Nervous System Lymphoma	City of Hope Medical Center	P1	D (21)
cd19-ucart Primary Central Nervous System Lymphoma	University of Colorado, Denver	P1	D (21)

Showing 2801 to 2825 of 3,186 assets

PreviousPage 113 of 128Next